Transcode Therapeutics
Price & Volume
Stats
See more52W Range | $6.14-$468.44 |
Market Cap | $7.8M |
Shares Short | 27,054 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$236.52 |
News
See moreYahoo Finance • last month
Sector Update: Health Care Stocks Advance Late Afternoon
Yahoo Finance • last month
Sector Update: Health Care Stocks Advance Wednesday Afternoon
Yahoo Finance • 2 years ago
TransCode Therapeutics Reports Third Quarter 2023 Results; Provides Business Update
About
CEO | Dr. Philippe P. Calais Ph.D., Pharm., Pharm.D. |
CFO | Mr. Thomas A. Fitzgerald M.B.A. |
Address | 6 Liberty Square, Boston, MA, United States, 02109 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 7 |
